Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 Study

By afschroeder • October 29, 2026

McKean M, Chmielowski B, Butler MO, Carvajal RD, Rodon J, Carlino MS, Kim KB, Wise-Draper TM, Khan S, Salama AKS, Moser J, Ang A, Barrios K, Sachdev JC, Wilner KD, Cole GW Jr, Kwei L, Beaupre DM, Orloff M. Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 Study. J Clin Oncol. 2026 Oct 28:JCO2600802. doi: 10.1200/JCO-26-00802. Epub ahead of print. PMID: 42950186.

Tags: Hematology/Oncology, Publications

Results from a Phase II Single Arm Trial Evaluating the Safety and Efficacy of Anhydrous Enol-Oxaloacetate on Improving Cognitive Complaints in Breast Cancer Survivors

Ganz PA, Van Dyk K, Crespi CM, Petersen L, Sedrak MS, Bower JE. Results from a Phase II Single Arm Trial Evaluating the Safety and[...]

Conversational artificial intelligence for geriatric screening: A mixed-methods feasibility study

Naeim A, Cheng J, Spiegel B, Bakshian A, Tetrault E, Mehra M, Amini D, Krut Z, Shang H, Sedrak MS, Bui A, Johnson T, Wang[...]

Venous Thromboembolism in Pregnancy

Huynh K, Olevsky O, Mok T. Venous Thromboembolism in Pregnancy. Obstet Gynecol Clin North Am. 2026 Dec;53(4):723-746. doi: 10.1016/j.ogc.2026.07.001. Epub 2026 Sep 16. PMID: 42951441.